vs

Side-by-side financial comparison of DaVita (DVA) and UGI CORP (UGI). Click either name above to swap in a different company.

DaVita is the larger business by last-quarter revenue ($3.6B vs $2.1B, roughly 1.8× UGI CORP). UGI CORP runs the higher net margin — 14.4% vs 6.5%, a 7.9% gap on every dollar of revenue. On growth, DaVita posted the faster year-over-year revenue change (12.3% vs 3.9%). Over the past eight quarters, DaVita's revenue compounded faster (6.6% CAGR vs -7.5%).

DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.

UGI Corporation is a natural gas and electric power distribution company headquartered in King of Prussia, Pennsylvania, with extensive operations in the United States and Europe.

DVA vs UGI — Head-to-Head

Bigger by revenue
DVA
DVA
1.8× larger
DVA
$3.6B
$2.1B
UGI
Growing faster (revenue YoY)
DVA
DVA
+8.4% gap
DVA
12.3%
3.9%
UGI
Higher net margin
UGI
UGI
7.9% more per $
UGI
14.4%
6.5%
DVA
Faster 2-yr revenue CAGR
DVA
DVA
Annualised
DVA
6.6%
-7.5%
UGI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DVA
DVA
UGI
UGI
Revenue
$3.6B
$2.1B
Net Profit
$234.2M
$297.0M
Gross Margin
Operating Margin
15.5%
22.0%
Net Margin
6.5%
14.4%
Revenue YoY
12.3%
3.9%
Net Profit YoY
43.8%
-20.8%
EPS (diluted)
$3.22
$1.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DVA
DVA
UGI
UGI
Q1 26
$3.6B
Q4 25
$3.6B
$2.1B
Q3 25
$3.4B
$1.2B
Q2 25
$3.4B
$1.4B
Q1 25
$3.2B
$2.6B
Q4 24
$3.3B
$2.0B
Q3 24
$3.3B
$1.2B
Q2 24
$3.2B
$1.4B
Net Profit
DVA
DVA
UGI
UGI
Q1 26
$234.2M
Q4 25
$234.2M
$297.0M
Q3 25
$150.3M
$-13.0M
Q2 25
$199.3M
$-163.0M
Q1 25
$162.9M
$479.0M
Q4 24
$259.3M
$375.0M
Q3 24
$214.7M
$-273.0M
Q2 24
$222.7M
$-48.0M
Operating Margin
DVA
DVA
UGI
UGI
Q1 26
15.5%
Q4 25
15.5%
22.0%
Q3 25
14.8%
1.1%
Q2 25
15.9%
-6.8%
Q1 25
13.6%
26.6%
Q4 24
17.2%
24.5%
Q3 24
16.4%
-20.4%
Q2 24
15.9%
5.0%
Net Margin
DVA
DVA
UGI
UGI
Q1 26
6.5%
Q4 25
6.5%
14.4%
Q3 25
4.4%
-1.1%
Q2 25
5.9%
-12.0%
Q1 25
5.1%
18.2%
Q4 24
7.9%
18.9%
Q3 24
6.6%
-22.6%
Q2 24
7.0%
-3.6%
EPS (diluted)
DVA
DVA
UGI
UGI
Q1 26
$3.22
Q4 25
$3.22
$1.34
Q3 25
$2.04
$-0.08
Q2 25
$2.58
$-0.76
Q1 25
$2.00
$2.19
Q4 24
$3.08
$1.74
Q3 24
$2.50
$-1.26
Q2 24
$2.50
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DVA
DVA
UGI
UGI
Cash + ST InvestmentsLiquidity on hand
$700.7M
$251.0M
Total DebtLower is stronger
$10.2B
$6.0B
Stockholders' EquityBook value
$-651.1M
$5.0B
Total Assets
$17.5B
$15.8B
Debt / EquityLower = less leverage
1.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DVA
DVA
UGI
UGI
Q1 26
$700.7M
Q4 25
$700.7M
$251.0M
Q3 25
$736.5M
$335.0M
Q2 25
$739.4M
$350.0M
Q1 25
$511.9M
$426.0M
Q4 24
$846.0M
$240.0M
Q3 24
$1.1B
$213.0M
Q2 24
$437.2M
$183.0M
Total Debt
DVA
DVA
UGI
UGI
Q1 26
$10.2B
Q4 25
$10.2B
$6.0B
Q3 25
$10.2B
$6.5B
Q2 25
$10.1B
$5.7B
Q1 25
$9.6B
$6.6B
Q4 24
$9.2B
$6.6B
Q3 24
$9.3B
$6.4B
Q2 24
$8.5B
$6.3B
Stockholders' Equity
DVA
DVA
UGI
UGI
Q1 26
$-651.1M
Q4 25
$-651.1M
$5.0B
Q3 25
$-571.9M
$4.8B
Q2 25
$-369.6M
$4.9B
Q1 25
$-267.1M
$5.0B
Q4 24
$121.1M
$4.6B
Q3 24
$386.7M
$4.3B
Q2 24
$632.9M
$4.7B
Total Assets
DVA
DVA
UGI
UGI
Q1 26
$17.5B
Q4 25
$17.5B
$15.8B
Q3 25
$17.6B
$15.5B
Q2 25
$17.5B
$15.4B
Q1 25
$17.1B
$15.7B
Q4 24
$17.3B
$15.4B
Q3 24
$17.5B
$15.1B
Q2 24
$17.0B
$15.1B
Debt / Equity
DVA
DVA
UGI
UGI
Q1 26
Q4 25
1.19×
Q3 25
1.37×
Q2 25
1.17×
Q1 25
1.32×
Q4 24
75.76×
1.44×
Q3 24
23.95×
1.48×
Q2 24
13.35×
1.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DVA
DVA
UGI
UGI
Operating Cash FlowLast quarter
$66.0M
Free Cash FlowOCF − Capex
$-155.0M
FCF MarginFCF / Revenue
-7.5%
Capex IntensityCapex / Revenue
10.7%
Cash ConversionOCF / Net Profit
0.22×
TTM Free Cash FlowTrailing 4 quarters
$282.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DVA
DVA
UGI
UGI
Q1 26
Q4 25
$540.7M
$66.0M
Q3 25
$841.5M
$90.0M
Q2 25
$324.2M
$289.0M
Q1 25
$180.0M
$684.0M
Q4 24
$547.6M
$164.0M
Q3 24
$810.4M
$151.0M
Q2 24
$798.8M
$390.0M
Free Cash Flow
DVA
DVA
UGI
UGI
Q1 26
Q4 25
$395.3M
$-155.0M
Q3 25
$675.4M
$-168.0M
Q2 25
$203.1M
$67.0M
Q1 25
$36.8M
$538.0M
Q4 24
$377.0M
$-47.0M
Q3 24
$671.4M
$-115.0M
Q2 24
$674.1M
$185.0M
FCF Margin
DVA
DVA
UGI
UGI
Q1 26
Q4 25
10.9%
-7.5%
Q3 25
19.7%
-14.4%
Q2 25
6.0%
4.9%
Q1 25
1.1%
20.4%
Q4 24
11.4%
-2.4%
Q3 24
20.6%
-9.5%
Q2 24
21.2%
13.7%
Capex Intensity
DVA
DVA
UGI
UGI
Q1 26
Q4 25
4.0%
10.7%
Q3 25
4.9%
22.1%
Q2 25
3.6%
16.3%
Q1 25
4.4%
5.5%
Q4 24
5.2%
10.6%
Q3 24
4.3%
22.0%
Q2 24
3.9%
15.2%
Cash Conversion
DVA
DVA
UGI
UGI
Q1 26
Q4 25
2.31×
0.22×
Q3 25
5.60×
Q2 25
1.63×
Q1 25
1.10×
1.43×
Q4 24
2.11×
0.44×
Q3 24
3.77×
Q2 24
3.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons